Working on CDMO for Macromolecular Target Drugs
The company can provide high-efficiency purification process development services for the monoclonal antibody, bispecific antibodies, fusion proteins, and other biomacromolecule drugs to ensure the stability and reliability of the process, and can remove relevant impurities effectively with a high recovery rate. It can provide chromatographic feeding life validation and characteristics studies on the purification process for the phase of PC/PV.
◆High-efficiency screening for chromatographic feeding;
◆ Development and optimization of chromatography process;
◆ Development and optimization of virus removal/ inactivation process;
◆ Life validation of chromatographic feeding;
◆ Characteristics studies on the purification process.